---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "x1K9lh7946Pls+uZbEFevEhUX7O/0TQ4v2W6Uuk0RWVlKPAbxqmc3D1SjNr2uya9HxvpJ1pLa4jfVSnzL1RoNkHz+C0PuPVGJsyrPeUARUAkn+Ev78Li/k0VhBwmQ2IiNNzNHj7ucED9g/qsFlbXzA14kgrcnjC2WvlwGgUknQYzIZcTOlNnmeMTZCAl2BjRlc81pCRShEmoTxs1etKotiZWmwxkjEjoEoOKCkTh3nqkJBVzzXIRX16qrEoCS7ughiANJbgKQAD88RG7YcU5xaHQacN48pbLvx/1ae6KBlUgfo5PIgdL492IzQQkfzzkrD6Ltm9TtWWLgoSChx7UE87jUJSmHWIRz6QyjhJ8KEQ=;CWxcivWdYSfqWjpaT5trmA=="
---

